Prognos Health competitorsClear all

Prognos Health's top competitors include PathAI, Hindsait, OM1, Medial EarlySign and Tempus.
Prognos Health
Prognos Health
Prognos Health (formerly Medivo) is a company developing an AI-powered clinical lab test data platform.
PathAI
PathAI
PathAI is a company developing an AI-based platform technology for data-driven pathology analysis.
Hindsait
Hindsait
Hindsait’s SaaS platform applies artificial intelligence to large healthcare datasets, helping payors and providers improve patient health at a much lower cost.
OM1
OM1
OM1 is a healthcare technology company focused on providing outcomes measurement, comparison, and prediction of treatment outcomes.
Medial EarlySign
Medial EarlySign
Medial EarlySign develops an AI algorithmic platform for the discovery of clinical insights that indicate the likelihood of disease from basic medical information.
Tempus
Tempus
Tempus Labs is a genomics and data-analytics company.
Founding Date
Founding Date
2010
Founding Date
2016
Founding Date
2013
Founding Date
2015
Founding Date
2009
Founding Date
2015
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
New York, US HQ
Boston, US
Locations
Boston, US HQ
Austin, US
Locations
Hackensack, US HQ
Locations
Boston, US HQ
Locations
Aurora, US HQ
Hod Hasharon, IL
Locations
Chicago, US HQ
Employees
Employees
945% decrease
Employees
1453% increase
Employees
7
Employees
871% increase
Employees
393% increase
Employees
8743% increase
Twitter followers
Twitter followers
820
Twitter followers
733
Twitter followers
304
Twitter followers
N/A
Twitter followers
741
Twitter followers
2.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
13
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
0.7
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.9
Average likes per tweet (last 30 days)
11.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
446133
Alexa Website Rank
323544
Alexa Website Rank
395304
Alexa Website Rank
362767
Alexa Website Rank
383226
Alexa Website Rank
377318
Employee Rating
Employee Rating
3.0
Employee Rating
5.0
Employee Rating
N/A
Employee Rating
4.7
Employee Rating
N/A
Employee Rating
3.1

Funding

Latest funding round
Latest funding round
$ 20.5m (over 2 years ago)
Latest funding round
$ 75m (7 months ago)
Latest funding round
N/A
Latest funding round
$ 50m (5 months ago)
Latest funding round
$ 30m (about 2 years ago)
Latest funding round
$ 100m (3 months ago)
Total funding raised
Total funding raised
$ 43.2m
Total funding raised
$ 90.2m
Total funding raised
N/A
Total funding raised
$ 86m
Total funding raised
$ 30m
Total funding raised
$ 620m
For sources of this data, please see the company profile

View company profiles

PathAI
HQ
Boston, US
Employees
145↑ 3% increase

PathAI is a company developing an AI-based platform technology for data-driven pathology analysis.

View company
Hindsait
HQ
Hackensack, US
Employees
7

Hindsait’s SaaS platform applies artificial intelligence to large healthcare datasets, helping payors and providers improve patient health at a much lower cost.

View company
OM1
HQ
Boston, US
Employees
87↑ 1% increase

OM1 is a healthcare technology company focused on providing outcomes measurement, comparison, and prediction of treatment outcomes.

View company
Medial EarlySign
HQ
Aurora, US
Employees
39↑ 3% increase

Medial EarlySign develops an AI algorithmic platform for the discovery of clinical insights that indicate the likelihood of disease from basic medical information.

View company